BRCA2 and ovarian cancer: It is estimated that about 1 in 500 Americans have a mutation in BRCA1 or BRCA2. The lifetime risk of developing ovarian cancer with germline mutations in BRCA1 and BRCA2 is 40–60 and 11–27%, respectively (5–9).